Related Experiment Video
Updated: Mar 13, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
Translating Stem Cell Biology Into Drug Discovery.
Ilyas Singeç1, Anton Simeonov1
1National Institutes of Health (NIH). National Center for Advancing Translational Sciences (NCATS). Division of Pre-Clinical Innovation (DPI).
Induced pluripotent stem cells (iPSCs) offer new avenues for drug discovery and regenerative medicine. Current challenges remain in translating iPSC technology for widespread clinical use.
Area of Science:
- Stem cell biology
- Regenerative medicine
- Drug discovery
Background:
- Pluripotent stem cell research has advanced significantly.
- Induced pluripotent stem cells (iPSCs) are generated by reprogramming somatic cells.
- iPSCs hold promise for personalized medicine and disease modeling.
Purpose of the Study:
- To review the current state of induced pluripotent stem cell (iPSC) research.
- To identify challenges hindering clinical translation of iPSC technology.
- To reflect on future directions for the stem cell and translational communities.
Main Methods:
- Literature review of recent advancements in pluripotent stem cell research.
- Analysis of the applications of induced pluripotent stem cells (iPSCs) in drug discovery and regenerative medicine.
- Discussion of the hurdles in clinical implementation of iPSC-based therapies.
Main Results:
- Induced pluripotent stem cells (iPSCs) offer robust nuclear reprogramming.
- Patient- and disease-specific iPSCs enable expansion and differentiation into various cell types.
- iPSCs are becoming a key enabling technology across scientific disciplines.
Conclusions:
- Significant progress has been made in induced pluripotent stem cell (iPSC) research.
- Key challenges must be addressed to advance iPSC clinical applications.
- Further research is needed to bridge the gap between iPSC technology and patient care.
More Related Videos
08:04In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
Published on: May 11, 2021
07:43An Enzyme- and Serum-free Neural Stem Cell Culture Model for EMT Investigation Suited for Drug Discovery
Published on: August 23, 2016
Related Concept Videos
Stem Cell Culture
iPS Cell Differentiation
EPS and iPS Cells in Disease Research
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells